Skip to main content
PLOS One logoLink to PLOS One
. 2021 Jun 28;16(6):e0253701. doi: 10.1371/journal.pone.0253701

Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis

Rutchanee Rodpai 1, Oranuch Sanpool 1, Tongjit Thanchomnang 2, Pokkamol Laoraksawong 3, Lakkhana Sadaow 1, Patcharaporn Boonroumkaew 1, Arporn Wangwiwatsin 4, Chaisiri Wongkham 4, Porntip Laummaunwai 1, Wannaporn Ittiprasert 5, Paul J Brindley 5, Pewpan M Intapan 1, Wanchai Maleewong 1,*
Editor: Adler R Dillman6
PMCID: PMC8238218  PMID: 34181669

Abstract

Hyperinfection and disseminated infection by the parasitic nematode Strongyloides stercoralis can be induced by iatrogenic administration of steroids and immunosuppression and lead to an elevated risk of mortality. Responses of free-living stages of S. stercoralis to the therapeutic corticosteroid dexamethasone (DXM) were investigated using RNA-seq transcriptomes of DXM-treated female and male worms. A total of 17,950 genes representing the transcriptome of these free-living adult stages were obtained, among which 199 and 263 were differentially expressed between DXM-treated females and DXM-treated males, respectively, compared with controls. According to Gene Ontology analysis, differentially expressed genes from DXM-treated females participate in developmental process, multicellular organismal process, cell differentiation, carbohydrate metabolic process and embryonic morphogenesis. Others are involved in signaling and signal transduction, including cAMP, cGMP-dependent protein kinase pathway, endocrine system, and thyroid hormone pathway, as based on Kyoto Encyclopedia of Genes and Genomes analysis. The novel findings warrant deeper investigation of the influence of DXM on growth and other pathways in this neglected tropical disease pathogen, particularly in a setting of autoimmune and/or allergic disease, which may require the clinical use of steroid-like hormones during latent or covert strongyloidiasis.

Introduction

Strongyloides stercoralis is a soil-transmitted nematode that infects humans via skin penetration, eventually residing in the small intestine. S. stercoralis has a complex developmental cycle that exhibits both free-living and parasitic cycles [1]. It is generally difficult to obtain specimens of the parasitic stage, and moreover, an adult male parasitic stage is not known to occur. In contrast, as there are many human cases of strongyloidiasis and larvae can be recovered from feces, access to the free-living cycle of this human pathogen is less difficult. In this situation, the developmental cycle proceeds outside the human host in the external environment, giving rise to free-living forms of both adult male and female worms. First-stage larva excreted in the feces of the host can develop by two possible routes: direct (homogonic) development to an arrested larva (the filariform larva or infective stage larva) and indirect (heterogonic) development to a free-living adult stage. The adults mate and reproduce sexually, leading to release of the egg stage by free-living female worms. These eggs hatch into rhabditiform larvae, which in turn develop into filariform, infective larvae. The filariform larva initiates infection of a human host following direct penetration of skin, leading to the parasitic cycle within the host.

At least 600 million individuals worldwide may be infected with this parasite [2]. Many cases of infection with S. stercoralis are mild or asymptomatic. However, in acute infection, a characteristic cutaneous reaction may occur as the larva penetrates the skin, or pulmonary symptoms may be produced as the larva migrates through the lungs [3, 4]. In severe cases, over-proliferation of larvae can lead to hyperinfection and disseminated strongyloidiasis. Dissemination of the larvae to internal organs generally occurs only in high-risk groups, such as coinfection with human T-lymphotropic virus 1 infection (HTLV-1), during malignancy, in the context of alcoholism, and in children. Of particular concern are patients who become immunosuppressed or receive autoimmune disease treatment including corticosteroids [35]. With the high prevalence of S. stercoralis and the global geographical distribution of this parasite, the risk factors complicate and augment the burden of human strongyloidiasis [6, 7].

Although the molecular mechanisms linking strongyloidiasis with these risk factors remain unclear, the parasite appears to benefit from the suppressed innate and adaptive immune status conferred by concurrent glucocorticoid therapy, resulting in parasite reproduction, skin and tissue invasion and dissemination [3]. Moreover, steroid hormones have been proposed to serve as endogenous ligands of the S. stercoralis nuclear hormone receptor DAF-12, which regulates the reproductive process of the nematode [1, 8, 9]. Thus, elevated levels of exogenous corticosteroids may enhance the worm burden, especially during the indirect development route [9].

Dexamethasone (DXM) is a widely used steroid drug for the treatment and control of inflammation [10] and for Covid-19 disease [11]. DXM alters the immune response in animal models, where it is known to inhibit proliferation of eosinophils and mononuclear cells, to induce immunosuppression and to impair innate and adaptive immune responses [10, 12, 13]. DXM also enhances the fertility of the parasitic female Strongyloides venezuelensis in vivo, leading to an increased parasite burden, chronic strongyloidiasis, hyperinfection and/or dissemination [10]. Nonetheless, the direct effects of DXM treatment in humans with respect to enhanced fecundity of S. stercoralis during both the direct and indirect cycles of development awaits clarification at the transcriptome level.

Recently, expansive databases of transcriptomic data for S. stercoralis have become available, including RNA sequences of seven discrete developmental stages of the parasite [14]. In addition, the potential for modulated reproductive expression of S. stercoralis genes during steroid treatment has become apparent [1, 8]. Moreover, enhanced fecundity effects on S. stercoralis in the environment after exposure to steroids in the human bowel and excretion via feces are worthy of investigation. Such effects may increase the opportunity for population exposure to infective larvae and result in elevated prevalence and incidence in at-risk populations. This study employed a model to mimic iatrogenic exposure of S. stercoralis to medicinal steroids in infected humans. The model employed exposure of worms cultured in vitro on agar plates to DXM, followed by investigation of the transcriptome of free-living stages of S. stercoralis, including the parental free-living adult male and female stages. Using Illumina-based deep sequencing of total mRNA, we obtained insight into the genomic responses of this pathogenic nematode to this hormone-like agent.

Methods

Ethical considerations

The study protocol was approved by the Khon Kaen University Ethics Committee for Human Research (HE611059) with relevant guidelines and regulations of Ethical Principles for Medical Research Involving Human Subjects by the Declaration of Helsinki. Written informed consent was obtained from adult participants and from the parents or legal guardians of minors.

Strongyloides stercoralis worm and agar plate culture

Strongyloides stercoralis worms were obtained from the fecal samples of infected asymptomatic patients without corticosteroid treatment. Fecal samples from 30 individual cases of strongyloidiasis were cultured using the agar plate technique [15]. Each stool sample was divided into two groups: one used for the control group (non-DXM) and the other for the test group (DXM). For the DXM group, dexamethasone (approximately 3.6 mg) was spread on a 1.5% nutrient agar plate (9 cm diameter plate) and air dried for 30 min. Thereafter, three grams of stool was placed on the center of the plate; at least three plates/individual fecal samples both with and without the inclusion of DXM were used. Then the plate was maintained for 72 hours at 27° C. The free-living adults were harvested individually, washed several times in distilled water, preserved in RNAlater solution and stored at −20° C (S1 Fig). Following this incubation, representative fecal samples of the control group (non-DXM; n = 8, each) and test group (DXM; n = 8, each) were selected for investigation of the numbers of worms according to several developmental stages, i.e., 1) rhabditiform larvae, 2) filariform larvae, 3) free-living adult-stage males, and 4) free-living adult-stage females. The ratios of filariform larvae and the total numbers of free-living adults and filariform larvae were used to calculate the homogonic index [16] and evaluated using the Wilcoxon matched-pairs signed-ranks test in STATA Version 10.1.

RNA extraction

Total RNA was extracted from each sample (50 μl of worms) of pooled free-living adult males or females that had been preserved in RNAlater using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. In brief, the RNA was separated using chloroform, precipitated with isopropanol, and the pellet washed with ethanol and resuspended in RNase-free water. Thereafter, the RNA was incubated with DNase I (New England Biolabs Inc, Ipswich, MA) to remove residual DNA and stored at −70° C. The concentration and purity of the RNA was determined at 260 nm (NanoDrop 2000 Spectrophotometer, Thermo Fisher Scientific, Wilmington, DE). The RNA integrity was monitored by agarose gel electrophoresis and staining with ethidium bromide (S2 Fig).

cDNA synthesis and illumina sequencing

One microgram of total RNA per sample was used to construct each library to be sequenced according to the BGI self-sequencing system (Beijing Genomics Institute (BGI), Guangdong, China). Following extraction of total RNA and incubation in the presence of DNase I, mRNA was isolated using oligo(dT) and fragmented into small pieces. cDNAs were synthesized using the mRNA fragments as templates. Short cDNA fragments were purified, end-repaired, 3′ adenylated, and ligated to Illumina-compatible adapters. Suitably sized fragments were selected for PCR amplification. During the quality control steps, an Agilent 2100 Bioanalyzer and ABI StepOnePlus Real-Time PCR System were used to quantify and qualify the libraries. Nucleotide sequences of the libraries were determined using the Illumina HiSeq 4000 platform by BGI.

De novo transcriptome assembly-focused methods

Following deep sequencing, low-quality reads of < 15, which constituted > 20% of the read, reads that included > 5% unknown bases (N), and adapters were filtered and removed using the vendor’s (BGI) internal software. De novo assembly of these transcripts was undertaken using these filtered clean reads and the Trinity program (version: v2.0.6) [17], which combines three independent software modules, Inchworm, Chrysalis, and Butterfly. Thereafter, Tgicl (version: v2.0.6) [18] was used to cluster the transcripts, with the resulting clusters termed unigenes.

To achieve functional annotations, the default parameters of the software tools were used, and unigenes were aligned to the nucleotide sequence database (Nt) (ftp://ftp.ncbi.nlm.nih.gov/blast/db), non-redundant protein sequence database (Nr) (ftp://ftp.ncbi.nlm.nih.gov/blast/db), Cluster of Orthologous Groups of proteins (COG) (http://www.ncbi.nlm.nih.gov/COG), Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg), and SwissProt (http://ftp.ebi.ac.uk/pub/databases/swissprot) using BLAST [19]. In addition, further annotations were performed using Blast2GO [20] with Nr annotation to obtain Gene Ontology (GO) (http://geneontology.org) annotations and using InterProScan5 [21] for InterPro annotations (http://www.ebi.ac.uk/interpro).

Following transcriptome assembly, cleaned sequencing data were mapped to unigenes with Bowtie2 [22], and gene expression levels in fragments per kilobase million (FPKM) values were calculated with RSEM [23]. The FPKM heatmap of all unigenes from four individual samples was generated using the pheatmap package in R software [24]. To construct the heatmap, a value of 1 was added to each raw FPKM value prior to log2 transformation to avoid log2 (0). To compare unigene expression levels in two samples, in particular, female control (Fc) versus male control (Mc), female control (Fc) versus female treated (Ft), male control (Mc) versus male treated (Mt), and male treated (Mt) versus female male treated (Ft), unigenes with log2-fold change > 3.00 or < -3.00 and FDR < 0.001 were considered differentially expressed genes (DEGs) by the PoissonDis method [25]. KEGG and GO analyses of DEGs were classified according to official classifications, and functional enrichment was performed using phyper, a function of R software. The P value was calculated as a formula in the hypergeometric test and used to calculate the FDR. In general, terms were defined as significantly enriched when FDR was not > 0.001.

Mapping to the reference genome

The reads were refiltered as follows: low-quality reads with < 20 that constituted > 50% of the read and reads with unknown bases (N) at > 10% of the residues were trimmed using Trimmomatic (version 0.39) [26]. Subsequently, the remaining cleaned reads were mapped to the draft genome sequence of Strongyloides stercoralis (genome project PRJEB528, https://parasite.wormbase.org/Strongyloides_stercoralis_prjeb528/Info/Index/) [27] using HISAT2 (version 2.1.0) [28]. Gene expression levels in gene count, transcript count, FPKM, and transcripts per million (TPM) values were calculated with StringTie (version 2.1.1) [29, 30]. From the read count data, differential gene expression analysis was performed using DESeq2 with a blind protocol. Genes with log2-fold change > 3.00 or < -3.00 were defined as DEGs. In addition, GO enrichment analysis was undertaken using WEGO (http://www.geneontology.org/) [31] and KEGG enrichment pathway analysis using BlastKOALA (https://www.kegg.jp/blastkoala/) [32].

Results

Effect of dexamethasone on Strongyloides stercoralis during development on agar

Out of 30 individual samples, feces from each of eight strongyloidiasis cases were used for the worm classification in development cycle. At 72 hours of agar plate culture, the worms were classed as free-living males, free-living females, post free-living rhabditiform larvae and post-parasitic filariform larvae of S. stercoralis, and the numbers of worms in each class were evaluated using a Wilcoxon matched-pairs signed-ranks test. Median numbers were significantly different between the DXM-treated and non-DXM-treated free-living females and between the rhabditiform larvae exposed or not to DXM (P < 0.05 in each case) (Table 1). Moreover, the ratio of rhabditiform larvae to filariform larvae in the DXM treatment group was significantly higher than that in the non-DXM group (Table 1).

Table 1. Median numbers of indirect development of human S. stercoralis from agar plate cultures maintained for 72 hours in the presence or absence of dexamethasone (DXM).

Non-DXM treated Median (min:max) DXM treated Median (min:max) P value 95%CI
Free-living male 4.34 (1:19.5) 5.25 (1: 25.25) 0.23 -1.5 to 4.22
Free-living female 11.00 (1:71) 18.03 (1:100.5) 0.03* 1 to 24.38
Free-living female/free-living male ratio 2.23 (0.4:15.93) 3.24 (1:7.92) 0.44 -3.84 to 1.66
Rhabditiform larva1 832.5 (0: 23415) 2173.75 (0:32730) 0.04* 0.0 to 6654.38
Rhabditiform larva/ free-living female ratio 48.71 (0:329.79) 125.42 (0:325.67) 0.62 -105.63 to 150.10
Filariform larva2 1985 (0:16215) 459.69 (0:6090) 0.07 -5926.56 to 30
Rhabditiform larva/ filariform larva ratio 0.67 (0.13:1.44) 3.58 (0: 5.37) 0.02* 2.01 to 4.10
Filariform larva/free-living female ratio 111.74 (0: 748) 29.21 (0: 112.5) 0.05 -410.79 to 5.65
Homogonic index 0.99 (0: 1.0) 0.96 (0: 0.98) 0.52 -0.04 to 0.03

*P ≤ 0.05, N = 8

1 developing S. stercoralis post free-living rhabditiform larvae.

2 developing S. stercoralis post parasitic filariform larvae.

Overview of the transcriptome assembly

Four cDNA libraries were prepared from DXM-treated free-living females (treated females; Ft) or males (treated males; Mt) and untreated free-living females (female control; Fc) or males (male control; Mc) and sequenced using the Illumina paired-end reads approach. In total, 26.42 gigabases were generated for the four libraries following the removal of poor-quality reads. Based on the de novo assembly, 65.64, 65.23, 66.74 and 66.71 million clean reads were obtained after filtering of the sequencing raw reads for Fc, Ft, Mc and Mt worms, respectively (Table 2). Overall, we recovered 18,226 unigenes that were subsequently compared against public databases, including NCBI non-redundant protein sequences (Nr), NCBI nucleotide sequences (Nt), protein family annotation (SwissProt), Kyoto Encyclopedia of Genes and Genomes (KEGG), Clusters of Orthologous Groups database (COG), InterPro annotation, and Gene Ontology (GO). Further analysis involved mapping quality clean reads to the S. stercoralis genome (genome project PRJEB528), with 63.60, 63.18, 64.04 and 64.08 million reads of the Fc, Ft, Mc and Mt worms, respectively, mapped (Table 2). Based on annotation with the reference S. stercoralis genome, a total of 10,484 (cutoff > 3) transcribed genes were obtained (Table 2).

Table 2. Summary statistics for transcriptome analysis by de novo assembly and mapping to the S. stercoralis genome.

Female control (Fc) Female DXM treated (Ft) Male control (Mc) Male DXM treated (Mt)
Total raw reads (million) 70.14 70.14 72.40 72.40
De novo assembly analysis
Total clean reads (million) 65.64 65.23 66.74 66.71
Total number of transcripts 20,443 20,775 21,139 20,239
Mean length of transcripts (nt) 1066 1075 1042 1029
N50 of transcripts 1732 1744 1679 1624
GC percentage 28.34 28.34 28.19 28.29
Total number of unigenes 15,303 15,396 16,322 15,538
Mean length of unigenes (nt) 1177 1187 1137 1124
N50 of unigenes 1781 1808 1734 1672
GC percentage 28.35 28.37 28.23 28.35
All unigenes = 18,226 (mean length = 1373, N50 = 2084, GC percentage = 28.07)
Reference genome mapping analysis
Total clean reads (million) 65.60 65.20 66.69 66.67
Total mapped reads (million) 63.60 63.18 64.04 64.08
GC percentage 34.02 34.12 34.34 34.53
Number of expressed gene
cutoff > 0 (Total genes = 12,772) 12,292 12,320 12,039 11,919
cutoff > 3 (Total genes = 10,484) 8,250 8,296 7,970 7,781
All reference genome mapped genes = 13,098

Transcriptome profiles of the free-living adults of S. stercoralis

Following de novo assembly, clean reads were mapped to unigenes, and the gene expression level for each sample was calculated; 17,950 unigenes were identified (S1 Table), with 16,291, 16,285, 16,288, and 15,892 unigenes being expressed in the Fc, Ft, Mc, and Mt stages, respectively. Many expressed genes were shared among the samples. Specifically, the numbers of expressed genes shared between Fc and Ft, Fc and Mc, Ft and Mt, and Mc and Mt were 15,486, 15,066, 14,775, and 15,220, respectively (Fig 1A). The level of normalized fragments per kilobase million (FPKM) was used to represent transcription levels among the RNA-seq libraries. This revealed gene expression level differences between Ft and Fc and between Mt and Mc (Fig 1B), indicating that exposure to DXM induced transcriptional changes. In addition, notable effects of sex on gene expression patterns were observed, whereby the transcription levels between Fc and Mc worms showed marked differences in gene expression between males and females (Fig 1B).

Fig 1. Differential gene expression pattern of free-living adult S. stercoralis based on the de novo assembly.

Fig 1

(A) Venn diagram showing the number of unique and shared expressed genes among samples. (B) Expression profiles of all expressed unigenes are represented in the heatmap, where red and blue indicate higher and lower expression levels, respectively. To construct the heatmap, raw FPKM values were log2-transformed after a value of 1 was added to the raw value to avoid log2(0). (C) DEGs were defined as a unigene with log2-fold change > 3.00 or < -3.00 and FDR < 0.001. DEGs with higher expression levels in Ft than in Fc (FcVSFt), Ft than in Mt (MtVSFt), Fc than in Mc (McVSFc), or Mt than in Mc (McVSMt) were defined as “Upregulated”; those with lower expression levels were defined as “Downregulated” (Fc = female control, Ft = female DXM treated, Mc = male control, Mt = male DXM treated).

Similarly, the S. stercoralis mapped gene set was used to estimate the gene expression level by counting the reads that mapped to genes. Hierarchical clustering of the sample-to-sample distances from normalized gene counts (using the Rlog function of DESeq2) demonstrated dissimilarities between DXM-induced samples and a large difference between the sexes, as shown by a principal component analysis plot (S3 Fig).

Differential gene expression pattern of free-living male and female adults in response to dexamethasone

Based on the de novo assembly, putative differentially expressed genes (DEGs) were identified using the PossionDis algorithms with a cutoff at false discovery rate (FDR) < 0.001 and a log2 fold change > 3.00 or < -3.00 to identify up- or downregulated DEGs (S2 Table). Employing independence sample analysis and a strict cutoff, four pairwise comparisons were performed to identify DEGs of Fc versus Ft (199 genes identified as DEGs), Mt versus Ft (3,109 genes), Mc versus Fc (2,941 genes), and Mc versus Mt (263 genes), as depicted in Fig 1C.

Based on the reference genome mapping, a cutoff value of log2 fold change > 3.00 or < -3.00 identified DEGs. Comparisons were performed to identify DEGs of Fc versus Ft (536 genes identified as DEGs) and Mc versus Mt (609 genes). Moreover, cluster analysis was applied to identify genes with similar expression patterns under different experimental conditions (Fc, Ft, Mc, and Mt). The top 30 DEGs were obtained (S3 Table). With respect to the sex comparison, a total of 1,943 transcripts were differentially expressed between male and female worms (adjusted P value < 0.05 and log2 fold change > 3.00 or < -3.00) (S4 Table).

GO classification analysis

To infer the effects of the transcriptional changes, DEGs from the four pairwise comparisons of de novo analysis were used for an analysis of GO term enrichment (Fig 2). For Fc versus Ft, enriched GO terms in the biological process category were: developmental process, multicellular organismal process, single organism process, biological regulation, cellular process, reproduction, and metabolic process. For Mc versus Mt, the most enriched biological process GO terms were: cellular component organization or biogenesis, developmental process, and multicellular-single organismal process. In contrast, GO terms involved in the regulation of biological process and behavior or response to stimulus seemingly were not enriched among upregulated genes in DXM-treated males when compared to Fc versus Ft. Accordingly, GO enrichment analysis of DEGs in the mapped reference genome data showed that the most enriched GO terms in the biological process category were similar and included: biological regulation, metabolic process, cellular process, regulation of biological process, response to stimulus, signaling, cellular component organization or biogenesis, positive regulation of biological process, and multicellular organismal process (S4 Fig).

Fig 2. Gene Ontology (GO) enrichment analysis of differentially expressed genes between samples.

Fig 2

Upregulated genes in enriched GO terms are indicated by red bars, and those with downregulated expression are indicated in blue. FcVSFt; female control versus female DXM treated, MtVSFt; male DXM treated versus female DXM treated, McVSFc; male control versus female control, McVSMt; male control versus male DXM treated.

For the sex comparison, male vs female, frequent GO terms observed were: cellular process, developmental process, multicellular-single organismal process, regulation of biological process, biological regulation, and metabolic process (Fig 2; S4 Fig).

Classification analysis of KEGG pathways

To identify biological pathways in response to DXM treatment, the de novo based-DEGs were mapped to the KEGG protein database. Fig 3 presents the pathways in KEGG classified into six main biochemical pathways: organismal systems, metabolism, human diseases, genetic information processing, environmental information processing, and cellular processes. The signal transduction pathway was the most prominent pathway both in comparisons of Fc versus Ft and Mc versus Mt, suggesting that DXM may affect the cell communication of the free-living stages of the worm. Among the KEGG enrichment of DEGs from each comparison, selected significantly enriched pathways are listed in Table 3, with the complete results provided in S5 Table. For Fc versus Ft, free-living females treated with DXM showed DEGs related to signal transduction and the endocrine system. For Mc versus Mt, free-living males treated with DXM exhibited DEGs related to the extracellular matrix (ECM)-receptor interaction pathway and ubiquitin-mediated proteolysis pathway.

Fig 3. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of differentially expressed genes (DEGs) between samples.

Fig 3

DEGs that were upregulated are indicated in orange and color gradations of orange, whereas downregulated transcripts are shown in blue and color gradations of blue. FcVSFt; female control versus female DXM treated, MtVSFt; male DXM treated versus female DXM treated, McVSFc; male control versus female control, McVSMt; male control versus male DXM treated.

Table 3. Selected KEGG pathway analysis from DEGs based on de novo assembly.

Pathway* DEGs genes with pathway annotation All genes with pathway annotation Pathway ID
FcVSFt (DEGs = 199)
cAMP signaling 7(3.52%) 372 (3.5%) ko04024
cGMP-PKG signaling 6 (3.02%) 297 (2.79%) ko04022
Oxytocin signaling 8(4.02%) 275 (2.59%) ko04921
Calcium signaling 7(3.52%) 251 (2.36%) ko04020
Thyroid hormone signaling 10 (5.03%) 242 (2.28%) ko04919
Renin secretion 6 (3.02%) 147 (1.38%) ko04924
Long-term potentiation 7(3.52%) 133 (1.25%) ko04720
Insulin secretion 5 (2.51%) 134 (1.26%) ko04911
Thyroid hormone synthesis 5 (2.51%) 114 (1.07%) ko04918
Endocrine and other factor-regulated calcium reabsorption 6 (3.02%) 109 (1.03%) ko04961
McVSMt (DEGs = 263)
ECM-receptor interaction 4 (1.5%) 181 (1.7%) ko04512
Ubiquitin mediated proteolysis 8 (3.04%) 153 (1.44%) ko04120
McVSFc (DEGs = 2941)
Pyrimidine metabolism 20 (0.68%) 136 (1.28%) ko00240
Adherens junction 45 (1.53%) 160 (1.51%) ko04520
p53 signaling 12 (0.41%) 47 (0.44%) ko04115
MtVSFt (DEGs = 3109)
Spliceosome 33 (1.06%) 228 (2.15%) ko03040
mRNA surveillance 52 (1.67%) 168 (1.58%) ko03015
DNA replication 9 (0.29%) 43 (0.4%) ko03030
Notch signaling 21 (0.68%) 85 (0.8%) ko04330
Adherens junction 48 (1.54%) 160 (1.51%) ko04520
Cell cycle 33 (1.06%) 143 (1.35%) ko04110
Insulin resistance 44 (1.42%) 136 (1.28%) ko04931
Pyrimidine metabolism 20 (0.64%) 136 (1.28%) ko00240
Focal adhesion 82 (2.64%) 338 (3.18%) ko04510
Thyroid hormone signaling 55 (1.77%) 242 (2.28%) ko04919

*The pathways have q-values ≤ 0.05 based on genes that are involved in community or signal transformation or the endocrine system and high gene numbers in each pathway.

Regardless, the most enriched KEGG pathways of the genome mapping based-DEGs were associated with metabolism, including glycosaminoglycan degradation, thiamine metabolism and purine metabolism pathways in free-living females treated with DXM. For free-living males treated with DXM, enriched KEGG pathways included glycosaminoglycan degradation, thiamine metabolism and purine metabolism, drug metabolism-other enzyme pathways, and metabolism of xenobiotics by cytochrome P450. Notably, the latter pathway participates in responses to the external environment, with responses affecting several signal transduction pathways (S5 Fig).

Signaling pathways in the free-living adult stage of S. stercoralis in response to dexamethasone

KEGG pathway enrichment analysis of DEGs was performed from each comparison. Selected analysis of the most significantly enriched pathways showed that the signaling system was the most significantly enriched pathway (q-value ≤ 0.05) (Table 3; S5 Table). For Fc versus Ft, signaling pathways including cAMP signaling, cGMP-PKG signaling, oxytocin signaling, and calcium signaling were among the enriched pathways. Many genes in the pathways are associated with several unigenes and shared among multiple signaling pathways, as listed in Table 3. For example, protein kinase A (PKA) is a key protein involved in several pathways and is central to the cAMP signaling pathways, as illustrated in Fig 4.

Fig 4. Up- and down-regulated DEGs in the adenosine 3’,5’-cyclic monophosphate (cAMP) signaling pathway (map04024) between female control versus female DXM treated (FcVSFt).

Fig 4

Red boxes indicate upregulated genes in DXM-treated female worms. Green boxes indicate downregulated genes in DXM-treated female worms. (KEGG database network diagram; KEGG website; https://www.genome.jp/dbget-bin/www_bget?map04024).

Accession numbers

All sequence reads have been deposited in the NCBI Sequence Read Archive (SRA) under project accession number PRJNA636286.

Discussion

With advancements in sequencing technologies, several Strongyloides species have been sequenced and characterized at the transcriptomic level, including S. stercoralis [14], S. venezuelensis [33], and S. ratti [34]. Strongyloides stercoralis is an agent of human strongyloidiasis, and its infection can lead to hyperinfection and disseminated strongyloidiasis, particularly in those who are immunosuppressed or undergoing corticosteroid-based treatment for an autoimmune disease [2, 3]. This study explored the effects of the corticosteroid drug dexamethasone (DXM) on the development of S. stercoralis recovered from human infection. We examined the numbers of parasites during four discrete developmental stages in culture on agar and investigated the transcriptomes of the free-living male and female stages of S. stercoralis. Exposure to DXM enhanced the numbers of free-living females and rhabditiform larvae in the indirect development phase of the life cycle. The ratio of rhabditiform larvae to filariform larvae in the DXM-treated worms was significantly higher than that in controls. Similarly, it has recently been reported that synthetic dafachronic acid, a class of corticosteroid hormones found in nematodes, also promotes indirect development of S. stercoralis [1]. Nevertheless, exposure to DXM was not associated with a significant effect with respect to development stage switching between the direct (homogonic) and indirect (heterogonic) routes of the free-living life cycle of S. stercoralis (P-value of homogonic index > 0.05). However, the number of free-living males did not significantly change between the DXM-treated group and controls, and the proportion of mean females per males in each group was ~ 3 times greater, a result that prompts further, in-depth genetic studies.

RNA-seq transcriptomic analysis of the parasite was performed to investigate molecular mechanisms that may be responsible for the observed effect on indirect development. To comprehensively compare free-living S. stercoralis after DXM treatment with control, non-DXM-treated worms, transcriptomic profiles were examined based on gene expression patterns, key functional annotations, and enrichment analyses of biological processes and pathways. A total of 18,226 unigenes were assembled and then used to calculate gene expression levels, which revealed expression of 17,950 unigenes. Searches were then performed using these unigenes, and annotations in public databases including NT, NR, SwissProt, InterPro, GO, COG, and KEGG databases were retrieved. Several important functions and key pathways associated with the DXM response were then obtained by GO and KEGG enrichment analyses of free-living adult DEGs. Using a stringent log2-fold change cutoff (log2FC > 3.00 or < -3.00), we observed varying numbers of up- and downregulated genes across all pairwise comparisons (Fig 1C). These new transcriptome data suggest that the DEGs of free-living females are involved in various signaling pathways, most of which are related to the regulation of development, reproduction, signal hormone transduction and cell division. Not surprisingly, the results suggest markedly different patterns of gene expression between non-DXM- and DXM-treated worms.

In addition, we examined the RNA-seq findings for the S. stercoralis genome. A total of 13,098 genes were mapped, and 10,484 (cutoff > 3) transcribed genes were obtained, showing the disadvantage of reference-guided assembly strategies: for instance, more diverged regions may not be covered and may be missing, leading to a lower number present in the target assembly [35, 36]. Nonetheless, the gene expression level pattern was similar to that of the de novo assembly analysis, and the top 30 up- and downregulated DEGs of both DXM-treated male and female worms were investigated according to these reference-based genes. Orthologs of genes of the model, free-living nematode Caenorhabditis elegans were identified (S3 Table), and among these, gnrr-7 (human gonadotropin-releasing hormone receptor (GnRHR) related) was upregulated in DXM-treated females. The activity of this receptor is mediated by association with G-proteins that respond to the environment and regulate the reproductive system [37]. In addition, orthologs of genes involved in larval diapause were down-regulated, including daf-31, several serpentine receptors, class T gene, and math-33 [3840]. For DXM-treated males, upregulated C. elegans ortholog genes are related to cell recognition, mechanical stimuli response and signaling process [4144]. Intriguingly, these included cyp-29A2 (cytochrome P450 family) orthologs and an ortholog of human cyp-4A11 (cytochrome P450 family 4 subfamily A member 11), which displays leukotriene-b4 20-monooxygenase activity that contributes to DXM metabolism in humans [43, 45]. This finding suggests that DXM may induce expression of this cyp-4A11 ortholog in free-living forms of S. stercoralis. Previously, inhibition of cytochrome P450 in S. stercoralis was found to affect larval development, with a change in transcript abundance across the developmental cycle [1].

Additionally, the gene expression patterns between females and males exhibited marked differences, but GO and pathway enrichment analyses of DEGs showed a likely symmetric pattern of upregulated unigenes (Fig 2). The most impacted pathways control pyrimidine metabolism, which affects the lifespan of C. elegans by regulating reproductive signals [46], and cellular processes, i.e., adherens junctions and the p53 signaling pathway that is involved in embryo morphogenesis and the germ line in C. elegans [47, 48] (McVSFc; Table 3). The data suggested that DEGs between females and males are mostly related to development and reproductive regulation. These results can serve as the foundation for future studies on free-living S. stercoralis females and males obtained from cultures of infected human feces. In turn, the findings will provide an enhanced understanding of the biology of this helminth pathogen.

Focusing on free-living females, Table 3 shows the 10 most significantly changed pathways. These DEGs are involved in signal transduction and endocrine system pathways that respond to the glucocorticoid DXM, including cAMP signaling, calcium signaling, oxytocin signaling, thyroid hormone signaling, and long-term potentiation. Among these pathways, a shared gene encodes protein kinase A (PKA). Upregulation of PKA, which is a main enzymatic component of the cAMP signaling pathway, is known to influence gene expression, apoptosis, tissue differentiation, and cellular proliferation [49]. As previously reported, DXM can be used as a direct agent to activate PKA and elevate cAMP production to examine downstream regulation mechanisms of the cAMP signaling pathway [5052]. However, DXM downregulates cyclic-nucleotide phosphodiesterase (PDE) transcription, which has been characterized in rat adipocytes to investigate glucocorticoid-inducing lipolysis via the cAMP-PKA pathway [52]. It is notable that DXM affected free-living S. stercoralis females in a manner reminiscent of its impact in vertebrates. Indeed, PKA signaling and function have been characterized in many eukaryotes, including several parasites [5356]. For example, the cAMP–PKA pathway in Plasmodium falciparum has been implicated in gametocyte differentiation [57] and in completion of the asexual cycle as well as reinvasion of erythrocytes [58, 59]. The cAMP-PKA signaling pathway has been implicated in protecting C. elegans worms against environmental stress, i.e., low temperatures [60]. In response to DXM, free-living S. stercoralis female displayed differential cAMP-PKA signaling pathway gene expression, which resulted in concurrent developmental and reproductive changes. This may enable tolerance to environmental stresses. Moreover, coordination with other signaling pathways was apparent (Table 3, Fig 3); for example, oxytocin signaling and thyroid hormone signaling may enhance growth and development. These signaling pathways play a role in reproductive-related behaviors and promote cell growth, development and differentiation and metabolic processes [61, 62].

For the free-living male, the effects of DXM on development processes were less marked than in the female worm. In fact, the findings for pathway enrichment of DEGs only identified two pathways: i) the ECM-receptor interaction pathway (involved in signaling molecules and interactions) and ii) the ubiquitin-mediated proteolysis pathway (involved in protein folding, sorting and degradation). Genes in these pathways include some significantly upregulated members, though most DEGs were downregulated in both pathways. These findings are intriguing and suggest that further studies on the influence of corticosteroid-like hormones on the EMC-receptor interaction and/ubiquitin-mediated proteolysis pathway in free-living S. stercoralis males will be informative. This report, nevertheless, provides the first transcriptomic profile of the free-living male stage of S. stercoralis.

The findings from this study confirmed that the glucocorticoid dexamethasone modifies developmental processes in the free-living stages of S. stercoralis. The changes observed in response to DXM in developmental pathways and the genes involved enhance our understanding of the biology of free-living S. stercoralis and the relationship between steroid-based therapy and increasing people at-risk by this pathogen. It will be valuable to investigate comparative effects by DXM and other corticosteroids on specific genes, specifically with regard to sex regulation, developmental pathways of free-living S. stercoralis stages, and DEGs in free-living females involved in various signaling pathways, the regulation of development-related processes, reproduction, signal hormone transduction and cell division. The lacking data and biological replicates need to be clarified in the further investigations. These types of studies should enhance our knowledge of the effects of steroid hormones on parasite biology, including on the heterogonic cycle of development, and enhance our understanding of the global spread of human strongyloidiasis and of the influence of environmental factors, including temperature, humidity, personal hygiene, and steroid drug use.

Further investigation on the effects of DXM on this pathogen with respect to iatrogenic administration of glucocorticoids during treatment of autoimmune diseases or allergies in patients at risk of latent infection with S. stercoralis is warranted. In general, newly described functional genomics approaches for investigation of the biology and pathophysiology of helminthiasis will be informative [6366].

Supporting information

S1 Fig. A schematic diagram of the cultures and treatment conditions.

(TIF)

S2 Fig. Agarose gel electrophoresis pattern of total RNA extracted.

Left, the total RNA pattern extracted from pooled free-living adult male control (Control), free-living adult male treated with DXM (Test). Right, the total RNA pattern extracted free-living adult female control (Control)and free-living adult female treated with DXM (Test). MW, DNA ladder marker.

(TIF)

S3 Fig. Principal component analysis (PCA) on the read counts of free-living adult S. stercoralis with or without dexamethasone treated base on the reference genome mapping analysis.

(TIF)

S4 Fig. Gene ontology (GO) of Fc versus Ft and Mc versus Mt targeted DEGs by WEGO 2.0.

(a) The WEGO histogram of Fc versus Ft and Mc versus Mt targeted DEGs. The x-axis displays the GO terms. The right y-axis shows the gene numbers, while the left y-axis shows the percentages. (b) Log of P-values of GO terms indicated the significant differences between the down and up-regulated genes.

(TIF)

S5 Fig. Metabolism of xenobiotics by cytochrome P450 pathway (map00980) of the free-living male.

Red boxes indicate significant genes in DXM-treated male worms.

(TIF)

S1 Table. All gene expression from de novo assembly analysis.

(XLSX)

S2 Table. Differentially expressed genes between sample based on the de novo genome assembly.

FcVSFt; female control versus female DXM treated, MtVSFt; male DXM treated versus female DXM treated, McVSFc; male control versus female control, McVSMt; male control versus male DXM treated.

(XLSX)

S3 Table. The top 30 differentially expressed genes by cluster analysis base on the reference genome mapping analysis.

(PDF)

S4 Table. Differentially expressed genes between male and female based on the reference genome mapping.

(XLSX)

S5 Table. List of significantly enriched KEGG pathways of DEGs.

(XLSX)

Data Availability

All sequence reads have been released at the NCBI Sequence Read Archive (SRA) under project accession number PRJNA636286.

Funding Statement

The grants from Thailand Research Fund, [Distinguished Research Professor grant no. DPG6280002; The Royal Golden Jubilee Ph.D. Program, grant no. PHD/0053/2556] and Khon Kaen University [Research and Graduate Studies Affairs grant no. RP64010; Faculty of Medicine grants no., IN61150 and DR63101]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Albarqi MMY, Stoltzfus JD, Pilgrim AA, Nolan TJ, Wang Z, Kliewer SA, et al. Regulation of life cycle checkpoints and developmental activation of infective larvae in Strongyloides stercoralis by dafachronic acid. PLOS Pathog. 2016;12: e1005358. doi: 10.1371/journal.ppat.1005358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Buonfrate D, Bisanzio D, Giorli G, Odermatt P, Fürst T, Greenaway C, et al. The global prevalence of Strongyloides stercoralis infection. Pathogens. 2020;9(6):468. doi: 10.3390/pathogens9060468 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schär F, Odermatt P, Khieu V, Panning M, Duong S, Muth S, et al. Evaluation of real-time PCR for Strongyloides stercoralis and hookworm as diagnostic tool in asymptomatic schoolchildren in Cambodia. Acta Trop. 2013;126: 89–92. doi: 10.1016/j.actatropica.2012.12.012 [DOI] [PubMed] [Google Scholar]
  • 4.Genta RM. Dysregulation of strongyloidiasis: a new hypothesis. Clin Microbiol Rev. 1992;5: 345–355. doi: 10.1128/CMR.5.4.345 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Krolewiecki A, Nutman TB. Strongyloidiasis: A Neglected Tropical Disease. Infect Dis Clin North Am. 2019;33: 135–151. doi: 10.1016/j.idc.2018.10.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Greaves D, Coggle S, Pollard C, Aliyu SH, Moore EM. Strongyloides stercoralis infection. BMJ. 2013;347. doi: 10.1136/bmj.f4610 [DOI] [PubMed] [Google Scholar]
  • 7.Fischer NJ. Strongyloides ‘Larva Currens’ following high dose dexamethasone for upper airway burns: A case report and brief review of the literature. Trop Med Surg. 2015;3: 180. [Google Scholar]
  • 8.Wang Z, Stoltzfus J, You Y, Ranjit N, Tang H, Xie Y, et al. The nuclear receptor DAF-12 regulates nutrient metabolism and reproductive growth in nematodes. PLOS Genet. 2015;11: e1005027. doi: 10.1371/journal.pgen.1005027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Patton JB, Bonne-Année S, Deckman J, Hess JA, Torigian A, Nolan TJ, et al. Methylprednisolone acetate induces, and Δ7-dafachronic acid suppresses, Strongyloides stercoralis hyperinfection in NSG mice. Proc Natl Acad Sci U S A. 2018;115: 204–209. doi: 10.1073/pnas.1712235114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Machado ER, Carlos D, Sorgi CA, Ramos SG, Souza DI, Soares EG, et al. Dexamethasone effects in the Strongyloides venezuelensis infection in a murine model. Am J Trop Med Hyg. 2011;84: 957–966. doi: 10.4269/ajtmh.2011.10-0490 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384: 693–704. doi: 10.1056/NEJMoa2021436 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tefé-Silva C, Souza DI, Ueta MT, Floriano EM, Faccioli LH, Ramos SG. Interference of dexamethasone in the pulmonary cycle of Strongyloides venezuelensis in rats. Am J Trop Med Hyg. 2008;79: 571–578. [PubMed] [Google Scholar]
  • 13.Ruano AL, López-Abán J, Fernández-Soto P, de Melo AL, Muro A. Treatment with nitric oxide donors diminishes hyperinfection by Strongyloides venezuelensis in mice treated with dexamethasone. Acta Trop. 2015;152: 90–95. doi: 10.1016/j.actatropica.2015.08.019 [DOI] [PubMed] [Google Scholar]
  • 14.Stoltzfus JD, Minot S, Berriman M, Nolan TJ, Lok JB. RNAseq analysis of the parasitic nematode Strongyloides stercoralis reveals divergent regulation of canonical dauer pathways. PLoS Negl Trop Dis. 2012;6: e1854. doi: 10.1371/journal.pntd.0001854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Arakaki T, Hasegawa H, Asato R, Ikeshiro T, Kinjo F, Saito A, et al. A new method to detect Strongyloides stercoralis from human stool. Jpn J Trop Med Hyg. 1988;16: 11–17. doi: 10.2149/tmh1973.16.11 [DOI] [Google Scholar]
  • 16.Viney ME, Matthews BE, Walliker D. On the biological and biochemical nature of cloned populations of Strongyloides ratti. J Helminthol. 1992;66: 45–52. doi: 10.1017/s0022149x00012554 [DOI] [PubMed] [Google Scholar]
  • 17.Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, Amit I, et al. Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat Biotechnol. 2011;29: 644–652. doi: 10.1038/nbt.1883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pertea G, Huang X, Liang F, Antonescu V, Sultana R, Karamycheva S, et al. TIGR Gene Indices clustering tools (TGICL): a software system for fast clustering of large EST datasets. Bioinforma Oxf Engl. 2003;19: 651–652. doi: 10.1093/bioinformatics/btg034 [DOI] [PubMed] [Google Scholar]
  • 19.Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215: 403–410. doi: 10.1016/S0022-2836(05)80360-2 [DOI] [PubMed] [Google Scholar]
  • 20.Conesa A, Götz S, García-Gómez JM, Terol J, Talón M, Robles M. Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinforma Oxf Engl. 2005;21: 3674–3676. doi: 10.1093/bioinformatics/bti610 [DOI] [PubMed] [Google Scholar]
  • 21.Quevillon E, Silventoinen V, Pillai S, Harte N, Mulder N, Apweiler R, et al. InterProScan: protein domains identifier. Nucleic Acids Res. 2005;33: W116–120. doi: 10.1093/nar/gki442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9: 357–359. doi: 10.1038/nmeth.1923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12: 323. doi: 10.1186/1471-2105-12-323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/. [Google Scholar]
  • 25.Audic S, Claverie JM. The significance of digital gene expression profiles. Genome Res. 1997;7: 986–995. doi: 10.1101/gr.7.10.986 [DOI] [PubMed] [Google Scholar]
  • 26.Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequencedata. Bioinforma Oxf Engl. 2014;30: 2114–2120. doi: 10.1093/bioinformatics/btu170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hunt VL, Tsai IJ, Coghlan A, Reid AJ, Holroyd N, Foth BJ, et al. The genomic basis of parasitism in the Strongyloides clade of nematodes. Nat Genet. 2016;48: 299–307. doi: 10.1038/ng.3495 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12: 357–360. doi: 10.1038/nmeth.3317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Pertea M, Pertea GM, Antonescu CM, Chang T-C, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33: 290–295. doi: 10.1038/nbt.3122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc. 2016;11: 1650–1667. doi: 10.1038/nprot.2016.095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ye J, Zhang Y, Cui H, Liu J, Wu Y, Cheng Y, et al. WEGO 2.0: a web tool for analyzing and plotting GO annotations, 2018 update. Nucleic Acids Res. 2018;46: W71–W75. doi: 10.1093/nar/gky400 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kanehisa M, Sato Y, Morishima K. BlastKOALA and GhostKOALA: KEGG Tools for Functional Characterization of Genome and Metagenome Sequences. J Mol Biol. 2016;428: 726–731. doi: 10.1016/j.jmb.2015.11.006 [DOI] [PubMed] [Google Scholar]
  • 33.Nagayasu E, Ogura Y, Itoh T, Yoshida A, Chakraborty G, Hayashi T, et al. Transcriptomic analysis of four developmental stages of Strongyloides venezuelensis. Parasitol Int. 2013;62: 57–65. doi: 10.1016/j.parint.2012.09.006 [DOI] [PubMed] [Google Scholar]
  • 34.Jaleta TG, Rödelsperger C, Streit A. Parasitological and transcriptomic comparison of Strongyloides ratti infections in natural and in suboptimal permissive hosts. Exp Parasitol. 2017;180: 112–118. doi: 10.1016/j.exppara.2016.12.003 [DOI] [PubMed] [Google Scholar]
  • 35.Schneeberger K, Ossowski S, Ott F, Klein JD, Wang X, Lanz C, et al. Reference-guided assembly of four diverse Arabidopsis thaliana genomes. Proc Natl Acad Sci U S A. 2011;108: 10249–10254. doi: 10.1073/pnas.1107739108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lischer HEL, Shimizu KK. Reference-guided de novo assembly approach improves genome reconstruction for related species. BMC Bioinformatics. 2017;18: 474. doi: 10.1186/s12859-017-1911-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Fielenbach N, Antebi A. C. elegans dauer formation and the molecular basis of plasticity. Genes Dev. 2008;22: 2149–2165. doi: 10.1101/gad.1701508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Halaschek-Wiener J, Khattra JS, McKay S, Pouzyrev A, Stott JM, Yang GS, et al. Analysis of long-lived C. elegans daf-2 mutants using serial analysis of gene expression. Genome Res. 2005;15: 603–615. doi: 10.1101/gr.3274805 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Chen D, Zhang J, Minnerly J, Kaul T, Riddle DL, Jia K. daf-31 encodes the catalytic subunit of N alpha-acetyltransferase that regulates Caenorhabditis elegans development, metabolism and adult lifespan. PLoS Genet. 2014;10: e1004699. doi: 10.1371/journal.pgen.1004699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Senchuk MM, Dues DJ, Schaar CE, Johnson BK, Madaj ZB, Bowman MJ, et al. Activation of DAF-16/FOXO by reactive oxygen species contributes to longevity in long-lived mitochondrial mutants in Caenorhabditis elegans. PLoS Genet. 2018;14: e1007268. doi: 10.1371/journal.pgen.1007268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Teichmann SA, Chothia C. Immunoglobulin superfamily proteins in Caenorhabditis elegans. J Mol Biol. 2000;296: 1367–1383. doi: 10.1006/jmbi.1999.3497 [DOI] [PubMed] [Google Scholar]
  • 42.Liachko N, Davidowitz R, Lee SS. Combined informatic and expression screen identifies the novel DAF-16 target HLH-13. Dev Biol. 2009;327: 97–105. doi: 10.1016/j.ydbio.2008.11.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Savas U, Hsu M-H, Johnson EF. Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Arch Biochem Biophys. 2003;409: 212–220. doi: 10.1016/s0003-9861(02)00499-x [DOI] [PubMed] [Google Scholar]
  • 44.Barnes TM, Jin Y, Horvitz HR, Ruvkun G, Hekimi S. The Caenorhabditis elegans behavioral gene unc-24 encodes a novel bipartite protein similar to both erythrocyte band 7.2 (stomatin) and nonspecific lipid transfer protein. J Neurochem. 1996;67: 46–57. doi: 10.1046/j.1471-4159.1996.67010046.x [DOI] [PubMed] [Google Scholar]
  • 45.Cummings BS, Lasker JM, Lash LH. Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. J Pharmacol Exp Ther. 2000;293: 677–685. [PubMed] [Google Scholar]
  • 46.Wan QL, Meng X, Fu X, Chen B, Yang J, Yang H, et al. Intermediate metabolites of the pyrimidine metabolism pathway extend the lifespan of C. elegans through regulating reproductive signals. Aging. 2019;11: 3993–4010. doi: 10.18632/aging.102033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Armenti ST, Nance J. Adherens junctions in C. elegans embryonic morphogenesis. Subcell Biochem. 2012;60: 279–299. doi: 10.1007/978-94-007-4186-7_12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lettre G, Kritikou EA, Jaeggi M, Calixto A, Fraser AG, Kamath RS, et al. Genome-wide RNAi identifies p53-dependent and -independent regulators of germ cell apoptosis in C. elegans. Cell Death Differ. 2004;11: 1198–1203. doi: 10.1038/sj.cdd.4401488 [DOI] [PubMed] [Google Scholar]
  • 49.Taylor SS, Buechler JA, Yonemoto W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem. 1990;59: 971–1005. doi: 10.1146/annurev.bi.59.070190.004543 [DOI] [PubMed] [Google Scholar]
  • 50.Al-Wadei HA, Takahasi T, Schuller HM. PKA-dependent growth stimulation of cells derived from human pulmonary adenocarcinoma and small airway epithelium by dexamethasone. Eur J Cancer Oxf Engl 1990. 2005;41: 2745–2753. doi: 10.1016/j.ejca.2005.09.001 [DOI] [PubMed] [Google Scholar]
  • 51.Keshwani MM, Kanter JR, Ma Y, Wilderman A, Darshi M, Insel PA, et al. Mechanisms of cyclic AMP/protein kinase A- and glucocorticoid-mediated apoptosis using S49 lymphoma cells as a model system. Proc Natl Acad Sci U S A. 2015;112: 12681–12686. doi: 10.1073/pnas.1516057112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Xu C, He J, Jiang H, Zu L, Zhai W, Pu S, et al. Direct effect of glucocorticoids on lipolysis in adipocytes. Mol Endocrinol Baltim Md. 2009;23: 1161–1170. doi: 10.1210/me.2008-0464 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Abel ES, Davids BJ, Robles LD, Loflin CE, Gillin FD, Chakrabarti R. Possible roles of protein kinase A in cell motility and excystation of the early diverging eukaryote Giardia lamblia. J Biol Chem. 2001;276: 10320–10329. doi: 10.1074/jbc.M006589200 [DOI] [PubMed] [Google Scholar]
  • 54.Bao Y, Weiss LM, Braunstein VL, Huang H. Role of protein kinase A in Trypanosoma cruzi. Infect Immun. 2008;76: 4757–4763. doi: 10.1128/IAI.00527-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Kurokawa H, Kato K, Iwanaga T, Sugi T, Sudo A, Kobayashi K, et al. Identification of Toxoplasma gondii cAMP dependent protein kinase and its role in the tachyzoite growth. PLoS One. 2011;6: e22492. doi: 10.1371/journal.pone.0022492 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Swierczewski BE, Davies SJ. A schistosome cAMP-dependent protein kinase catalytic subunit is essential for parasite viability. PLoS Negl Trop Dis. 2009;3: e505. doi: 10.1371/journal.pntd.0000505 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Kaushal DC, Carter R, Miller LH, Krishna G. Gametocytogenesis by malaria parasites in continuous culture. Nature. 1980;286: 490–492. doi: 10.1038/286490a0 [DOI] [PubMed] [Google Scholar]
  • 58.Lima WR, Tessarin-Almeida G, Rozanski A, Parreira KS, Moraes MS, Martins DC, et al. Signaling transcript profile of the asexual intraerythrocytic development cycle of Plasmodium falciparum induced by melatonin and cAMP. Genes Cancer. 2016;7: 323–339. doi: 10.18632/genesandcancer.118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Syin C, Parzy D, Traincard F, Boccaccio I, Joshi MB, Lin DT, et al. The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytes. Eur J Biochem. 2001;268: 4842–4849. doi: 10.1046/j.1432-1327.2001.02403.x [DOI] [PubMed] [Google Scholar]
  • 60.Liu F, Xiao Y, Ji X-L, Zhang K-Q, Zou C-G. The cAMP-PKA pathway-mediated fat mobilization is required for cold tolerance in C. elegans. Sci Rep. 2017;7: 638. doi: 10.1038/s41598-017-00630-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Qiu C, Liu S, Hong Y, Fu Z, Wei M, Ai D, et al. Molecular characterization of thyroid hormone receptor beta from Schistosoma japonicum and assessment of its potential as a vaccine candidate antigen against schistosomiasis in BALB/c mice. Parasit Vectors. 2012;5: 172. doi: 10.1186/1756-3305-5-172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Scott E, Hudson A, Feist E, Calahorro F, Dillon J, de Freitas R, et al. An oxytocin-dependent social interaction between larvae and adult C. elegans. Sci Rep. 2017;7: 10122. doi: 10.1038/s41598-017-09350-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Gang SS, Castelletto ML, Bryant AS, Yang E, Mancuso N, Lopez JB, et al. Targeted mutagenesis in a human-parasitic nematode. PLoS Pathog. 2017;13: e1006675. doi: 10.1371/journal.ppat.1006675 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Bryant AS, Ruiz F, Gang SS, Castelletto ML, Lopez JB, Hallem EA. A critical role for thermosensation in host seeking by skin-penetrating nematodes. Curr Biol CB. 2018;28: 2338–2347.e6. doi: 10.1016/j.cub.2018.05.063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Lok JB. CRISPR/Cas9 mutagenesis and expression of dominant mutant transgenes as functional genomic approaches in parasitic nematodes. Front Genet. 2019;10: 656. doi: 10.3389/fgene.2019.00656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Ittiprasert W, Mann VH, Karinshak SE, Coghlan A, Rinaldi G, Sankaranarayanan G, et al. Programmed genome editing of the omega-1 ribonuclease of the blood fluke, Schistosoma mansoni. eLife. 2019;8. doi: 10.7554/eLife.41337 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Adler R Dillman

15 Apr 2021

PONE-D-21-00163

Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis

PLOS ONE

Dear Dr. Maleewong,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The reviewers have brought up several serious concerns. The foremost being a concern about developmental timing in addition to a major concern regarding the use of environmental stages and their relevance to the parasitic stages and steroid-based therapy. Please carefully consider the reviewers comments and address them point-by-point.

Please submit your revised manuscript by May 30 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Adler R. Dillman, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

  1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

  1. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

  1. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

  1. Thank you for stating the following financial disclosure:

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

At this time, please address the following queries:

4a)         Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

4b)         State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

4c)          If any authors received a salary from any of your funders, please state which authors and which funders.

4d)         If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

  1. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Additional Editor Comments:

The reviewers have brought up several serious concerns. The foremost being a concern about developmental timing in addition to a major concern regarding the use of environmental stages and their relevance to the parasitic stages and steroid-based therapy. Please carefully consider the reviewers comments and address them point-by-point.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors of ” Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis” demonstrate that the free living stages of the S. stercoralis lifecycle do appear to respond to the presence of dexamethasone via the regulation of multiple different genes. While the data does not add significant understanding to the interaction between steroids and the parasitic stages, it does provide evidence that at least this life cycle stage can respond to the steroid.

Major Comments

1) Line 44 – While it is intriguing to discover that free living S. stercoralis do respond to the presence of dex they unlikely to encounter dex in the environment. With both the gerbil and NSG animal models available the recovery of the parasitic stages if possible and would provide a more accurate representation of the response of S. stercoralis to steroids. Line 462-463 states that it helps define the relationship between “steroid-based therapy”. Hyper infection and disseminated strongyloidiasis are due to the presence of corticosteroids and the parasitic stages of S. stercoralis. Please further explain how these results from the free-living stages applies to the understanding of the relationship between steroids and the parasitic stages. What was the rational for doing the analysis on free living stages

2) How was the concentration of Dex determined. Was it a physiological concentration that is found in feces after a patients treatment with the steroids? The author only gives 3.6mg per plate and no total volume so the reader is unable to determine the exact concentration.

3) While the authors did use multiple plates/individual and made multiple cDNA libraries from the parasites collected from the plates at 72 hours it appears that they growth and differentiation of the parasites isolated from the feces on agar plates was not done as a true replicate.

Reviewer #2: In this paper, the authors collect fecal samples from humans infected with Strongyloides stercoralis, incubate the feces on agar plates either in the presence or absence of the corticosteroid dexamethasone (DXM), and then look for transcriptional differences resulting from dexamethasone exposure. Corticosteroid treatment in infected individuals can result in disseminated strongyloidiasis, and while this paper looks at DXM exposure during the free-living rather than parasitic phase of the life cycle, the paper still has important implications for human health. A better understanding of how DXM affects worm growth and physiology could inform nematode control strategies. However, I have a number of issues with the experimental design of this study that in my opinion make the data difficult to interpret.

My major concern is whether DXM is affecting the timing of Strongyloides development. This study looks at a single time point. The authors count the number of male adults, female adults, iL3s, and free-living larvae present in the control vs. DXM-treated samples, but they do not examine the worms by DIC microscopy to determine, for example, whether the adults in the control vs. DXM-treated samples appear to be the same developmental age. A lot of the transcriptional changes the authors observe in control vs. DXM-treated samples have to do with “regulation of development, reproduction, signal hormone transduction, and cell division” (Line 391). These differences could arise due to a direct effect of DXM, or they could arise because DXM exposure either speeds up or slows down development. Without a careful analysis of development in the control vs. DXM-treated samples, and without looking at multiple time points, it’s impossible to distinguish between these possibilities.

Other comments:

1. More explanation of why the 72 h time point was chosen is needed. In lines 196-198, the authors say, “After 72 hours of agar plate culture, the worms were classed as free-living males, free-living females, post free-living rhabditiform larvae and post-parasitic filariform larvae of S. stercoralis.” How do the authors know that the iL3s are post-parasitic? Isn’t 72 h enough time for some of the post-free-living larvae to develop into iL3s? If DXM does alter developmental timing, isn’t this especially a concern for the DXM-treated worms?

2. Lines 193-196: “Fecal samples from 30 individual cases of strongyloidiasis were cultured using the agar plate technique [30] with and without dexamethasone (DXM); at least three plates/individual fecal samples both with and without the inclusion of DXM were used (S2 Fig). Feces from each of eight strongyloidiasis cases were used for the investigation.” This is confusing. Were feces from 30 individuals or 8 individuals used?

3. The first paragraph of the discussion states that DXM significantly affects the number of worms in the indirect phase of the life cycle, and then later states that DXM does not have a significant effect on whether worms enter the direct vs. indirect phase of the life cycle. The wording here is very confusing and needs to be clarified.

4. Line 57: 100 million seems like an outdated estimate of the number of individuals infected with Strongyloides. Haven’t more recent estimates put the number closer to 600 million?

5. The paper would benefit from careful editing. Some of the sentences don’t entirely make sense as written, such as this one: “However, the experiment was done without replicates, did not validate in worm genetic was because of different human host and environment, also confirming the statistical comparisons analysis.” I’m not sure I follow what the authors are trying to say here. Some grammatical edits are required for the figures as well, and also for the short title.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jun 28;16(6):e0253701. doi: 10.1371/journal.pone.0253701.r002

Author response to Decision Letter 0


30 May 2021

Point-by-point response to the reviewers’ comments

PONE-D-21-00163

Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis

PLOS ONE

Additional Editor Comments:

The reviewers have brought up several serious concerns. The foremost being a concern about developmental timing in addition to a major concern regarding the use of environmental stages and their relevance to the parasitic stages and steroid-based therapy. Please carefully consider the reviewers comments and address them point-by-point.

Reply: We thank you very much. Our responses to reviewers’ comments are provided below in blue ink.

Reviewer #1: The authors of “Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis” demonstrate that the free living stages of the S. stercoralis lifecycle do appear to respond to the presence of dexamethasone via the regulation of multiple different genes. While the data does not add significant understanding to the interaction between steroids and the parasitic stages, it does provide evidence that at least this life cycle stage can respond to the steroid.

Major Comments

1) Line 44 – While it is intriguing to discover that free living S. stercoralis do respond to the presence of dex they unlikely to encounter dex in the environment. With both the gerbil and NSG animal models available the recovery of the parasitic stages if possible and would provide a more accurate representation of the response of S. stercoralis to steroids.

Reply: This study aimed to examine fecundity effects on S. stercoralis in the environment after exposure to steroids in the human bowel and excretion via feces. Such enhanced effects may increase the opportunity for population exposure to infective larvae. If our hypothesis is true, regarding to the dexamethasone interferes the human immune system, also the dexamethasone has effect to worms and enhance reproductive growth, increased the worm burden and caused hyper-infection and passed the worms through feces to the environment. Moreover, the dexamethasone may still affect to the free-living worm that enhances worm fecundity and releasing more infective larvae transmitted to humans. This could, in turn, enhance the risk for high prevalence and infection rate into human populations. This study employed a model to mimic iatrogenic exposure of S. stercoralis to medicinal steroids in bowel of infected humans after expose to dexamethasone. To address the hypothesis, worms in feces were exposed to dexamethasone after which we investigated its impact on the transcriptome of the free-living adult stage. For clarity, we modified one sentence, lines 92-93, to “This study employed a model to mimic iatrogenic exposure of S. stercoralis to medicinal steroids in infected humans.”

Line 462-463 states that it helps define the relationship between “steroid-based therapy”. Hyper infection and disseminated strongyloidiasis are due to the presence of corticosteroids and the parasitic stages of S. stercoralis. Please further explain how these results from the free-living stages applies to the understanding of the relationship between steroids and the parasitic stages. What was the rational for doing the analysis on free living stages

Reply: We meant “The changes observed in response to DXM in developmental pathways and the genes involved enhance our understanding of the biology of free-living S. stercoralis and possibly explain the relationship between steroid-based therapy and increased opportunity for population exposure to infective larvae, which may in turn lead to elevated prevalence and incidence in at-risk populations.

For clarity, we modified the sentence to “The changes observed in response to DXM in developmental pathways and the genes involved enhance our understanding of the biology of free-living S. stercoralis and the relationship between steroid-based therapy and increasing people at-risk parasitism by this pathogen.” Please see lines 458-461.

2) How was the concentration of Dex determined. Was it a physiological concentration that is found in feces after a patients treatment with the steroids? The author only gives 3.6mg per plate and no total volume so the reader is unable to determine the exact concentration.

Reply: This is the approximate concentration from previous reports in experimental animals. Varying DXM concentration excreted in feces have been reported, within 96 hours, 44% of DXM dose will excrete in rat feces (Rice et al., 1974), whereas English et al. (1975) reported that within 96 hours, 24.8% of DXM dose in rats will have been excretes via the feces. In bovine feces, 95% was eliminated within 3 days (Vanhaecke et al. 2011).

Therefore, in this study, the DXM was covered on the agar. We used 3.6 mg DXM spread on 15 ml-settled agar, an amount calculated based on high-dose DXM (40mg/day) (Gutiérrez-Espíndola et al. 2003) and fecal excretion per day in a health person -- approximately 200 grams (Cummings et al. 1992). Thus, we employed 3.6 mg DXM, which mimics DXM exposure in the human gut lumen, equivalent to ([40 mg DXM/200 g feces] x 18 g (agar (15g)+feces (3g)) = 3.6 mg).

References

1. English J et al (1975). The metabolism of dexamethasone in the rat--effect of phenytoin. J Steroid Biochem. 6(1):65-8. doi: 10.1016/0022-4731(75)90030-8.

2. Rice et al. (1974) The metabolism of dexamethasone in the rat. Biochem. Soc. Transact., 53rd Meeting, Bristol, 2: 107-109.

3. Vanhaecke et al. (2011) Elimination kinetics of dexamethasone in bovine urine, hair and feces following single administration of dexamethasone acetate and phosphate esters. Steroids. 76(1-2):111-7.

4. Gutiérrez-Espíndola et al. (2003). High Doses of Dexamethasone in Adult Patients with Idiopathic Thrombocytopenic Purpura. Archives of Medical Research, 34(1), 31–34.

5. Cummings et al. (1992). Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology. 103(6):1783-9. doi: 10.1016/0016-5085(92)91435-7.

3) While the authors did use multiple plates/individual and made multiple cDNA libraries from the parasites collected from the plates at 72 hours it appears that they growth and differentiation of the parasites isolated from the feces on agar plates was not done as a true replicate.

Reply: We concur with the reviewer. The worms were collected from S. stercoralis infected persons. We have limited sample collections for RNA-S. stercoralis preparations. However, to clarify this point, we used the pooled worm samples from 30 patients and evaluation using the high cut-off value of gene expression level and analyzed with both the de novo assembly and genome mapping analysis to address this issue. We can aim to undertake the replicates recommended by the reviewer in future studies.

Reviewer #2: In this paper, the authors collect fecal samples from humans infected with Strongyloides stercoralis, incubate the feces on agar plates either in the presence or absence of the corticosteroid dexamethasone (DXM), and then look for transcriptional differences resulting from dexamethasone exposure. Corticosteroid treatment in infected individuals can result in disseminated strongyloidiasis, and while this paper looks at DXM exposure during the free-living rather than parasitic phase of the life cycle, the paper still has important implications for human health. A better understanding of how DXM affects worm growth and physiology could inform nematode control strategies. However, I have a number of issues with the experimental design of this study that in my opinion make the data difficult to interpret.

My major concern is whether DXM is affecting the timing of Strongyloides development. This study looks at a single time point. The authors count the number of male adults, female adults, iL3s, and free-living larvae present in the control vs. DXM-treated samples, but they do not examine the worms by DIC microscopy to determine, for example, whether the adults in the control vs. DXM-treated samples appear to be the same developmental age. A lot of the transcriptional changes the authors observe in control vs. DXM-treated samples have to do with “regulation of development, reproduction, signal hormone transduction, and cell division” (Line 391). These differences could arise due to a direct effect of DXM, or they could arise because DXM exposure either speeds up or slows down development. Without a careful analysis of development in the control vs. DXM-treated samples, and without looking at multiple time points, it’s impossible to distinguish between these possibilities.

Reply: We agree with the reviewer. These are the limitations of our study. However, to clarify these points, we used pooled worm samples from 30 patients and evaluation using the high cut-off value of gene expression level and analyzed with both the de novo assembly and genome mapping analysis to solve this problem. We can aim to undertake a multiple time points experiment in future studies.

Other comments:

1. More explanation of why the 72 h time point was chosen is needed. In lines 196-198, the authors say, “After 72 hours of agar plate culture, the worms were classed as free-living males, free-living females, post free-living rhabditiform larvae and post-parasitic filariform larvae of S. stercoralis.” How do the authors know that the iL3s are post-parasitic? Isn’t 72 h enough time for some of the post-free-living larvae to develop into iL3s? If DXM does alter developmental timing, isn’t this especially a concern for the DXM-treated worms?

Reply: At lower temperatures (20-28°C) than the human body (37°C), the free-living life cycle of Strongyloides develops completely from L1 to iL3 via indirect development for >72 hr (3-5 day) (Lok 2007). The first post-free-living L1 is present for about 48 hr (Lok 2007) whereas by 72 hr, it is presumed that the larvae still be in the post-free-living L2 stage. However, the developmental time points of the free-living life cycle of Strongyloides effected by DXM need further study. However, DXM does not significantly affect the number of filariform larvae (Table 1).

Lok, J.B. Strongyloides stercoralis: a model for translational research on parasitic nematode biology (February 17, 2007), WormBook, ed. The C. elegans Research Community, WormBook, doi/10.1895/wormbook.1.134.1, http://www.wormbook.org.

2. Lines 193-196: “Fecal samples from 30 individual cases of strongyloidiasis were cultured using the agar plate technique [30] with and without dexamethasone (DXM); at least three plates/individual fecal samples both with and without the inclusion of DXM were used (S2 Fig). Feces from each of eight strongyloidiasis cases were used for the investigation.” This is confusing. Were feces from 30 individuals or 8 individuals used?

Reply: Revised as recommended: results, page 9, lines 196 to 197; materials and methods, page 5, lines 107-114.

3. The first paragraph of the discussion states that DXM significantly affects the number of worms in the indirect phase of the life cycle, and then later states that DXM does not have a significant effect on whether worms enter the direct vs. indirect phase of the life cycle. The wording here is very confusing and needs to be clarified.

Reply: The initial sentences discussed how DXM significantly affects the number of free-living females and rhabditiform larvae in the indirect development phase of the life cycle; the ratio of rhabditiform larvae per filariform larvae in the DXM-treated worms was significantly higher than that in controls. The latter sentences dealt with the switching of the route to develop in the free-living life cycle that dexamethasone is not significantly affecting. The life cycle switching represents by homogonic index which is if the value nearly zero, it means that they are switching the route to heterogonic (indirect) development. Therefore, aiming for clarity, we have added “(P-value of homogonic index > 0.05)”. (page 20, lines 372).

4. Line 57: 100 million seems like an outdated estimate of the number of individuals infected with Strongyloides. Haven’t more recent estimates put the number closer to 600 million?

Reply: We have changed to reference [2] Buonfrate et al 2020, please see at page 3, lines 57.

5. The paper would benefit from careful editing. Some of the sentences don’t entirely make sense as written, such as this one: “However, the experiment was done without replicates, did not validate in worm genetic was because of different human host and environment, also confirming the statistical comparisons analysis.” I’m not sure I follow what the authors are trying to say here. Some grammatical edits are required for the figures as well, and also for the short title.

Reply: The meaning was similar that of the next sentence. For clarity, we deleted “However, the experiment was done without replicates, did not validate in worm genetic was because of different human host and environment, also confirming the statistical comparisons analysis.”

Finally, we would like to thank the reviewers for your kind suggestions.

Attachment

Submitted filename: Point by point response to Reviewer comments 29-5-21.docx

Decision Letter 1

Adler R Dillman

11 Jun 2021

Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis

PONE-D-21-00163R1

Dear Dr. Maleewong,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Adler R. Dillman, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for revising the manuscript to address the reviewer's concerns. This study contributes to our understanding of DXM-strongyloides interactions and should be of interest to the field.

Reviewers' comments:

Acceptance letter

Adler R Dillman

18 Jun 2021

PONE-D-21-00163R1

Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis

Dear Dr. Maleewong:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Adler R. Dillman

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. A schematic diagram of the cultures and treatment conditions.

    (TIF)

    S2 Fig. Agarose gel electrophoresis pattern of total RNA extracted.

    Left, the total RNA pattern extracted from pooled free-living adult male control (Control), free-living adult male treated with DXM (Test). Right, the total RNA pattern extracted free-living adult female control (Control)and free-living adult female treated with DXM (Test). MW, DNA ladder marker.

    (TIF)

    S3 Fig. Principal component analysis (PCA) on the read counts of free-living adult S. stercoralis with or without dexamethasone treated base on the reference genome mapping analysis.

    (TIF)

    S4 Fig. Gene ontology (GO) of Fc versus Ft and Mc versus Mt targeted DEGs by WEGO 2.0.

    (a) The WEGO histogram of Fc versus Ft and Mc versus Mt targeted DEGs. The x-axis displays the GO terms. The right y-axis shows the gene numbers, while the left y-axis shows the percentages. (b) Log of P-values of GO terms indicated the significant differences between the down and up-regulated genes.

    (TIF)

    S5 Fig. Metabolism of xenobiotics by cytochrome P450 pathway (map00980) of the free-living male.

    Red boxes indicate significant genes in DXM-treated male worms.

    (TIF)

    S1 Table. All gene expression from de novo assembly analysis.

    (XLSX)

    S2 Table. Differentially expressed genes between sample based on the de novo genome assembly.

    FcVSFt; female control versus female DXM treated, MtVSFt; male DXM treated versus female DXM treated, McVSFc; male control versus female control, McVSMt; male control versus male DXM treated.

    (XLSX)

    S3 Table. The top 30 differentially expressed genes by cluster analysis base on the reference genome mapping analysis.

    (PDF)

    S4 Table. Differentially expressed genes between male and female based on the reference genome mapping.

    (XLSX)

    S5 Table. List of significantly enriched KEGG pathways of DEGs.

    (XLSX)

    Attachment

    Submitted filename: Point by point response to Reviewer comments 29-5-21.docx

    Data Availability Statement

    All sequence reads have been released at the NCBI Sequence Read Archive (SRA) under project accession number PRJNA636286.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES